Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Toward optimal screening strategies for older women. Costs, benefits, and harms of breast cancer screening by age, biology, and health status.

Mandelblatt JS, Schechter CB, Yabroff KR, Lawrence W, Dignam J, Extermann M, Fox S, Orosz G, Silliman R, Cullen J, Balducci L; Breast Cancer in Older Women Research Consortium.

J Gen Intern Med. 2005 Jun;20(6):487-96.

2.

Cost-effectiveness of extending screening mammography guidelines to include women 40 to 49 years of age.

Salzmann P, Kerlikowske K, Phillips K.

Ann Intern Med. 1997 Dec 1;127(11):955-65. Erratum in: Ann Intern Med 1998 May 15;128(10):878.

PMID:
9412300
3.

Benefits and costs of interventions to improve breast cancer outcomes in African American women.

Mandelblatt JS, Schechter CB, Yabroff KR, Lawrence W, Dignam J, Muennig P, Chavez Y, Cullen J, Fahs M.

J Clin Oncol. 2004 Jul 1;22(13):2554-66. Epub 2004 Jun 1.

PMID:
15173213
4.

Continuing screening mammography in women aged 70 to 79 years: impact on life expectancy and cost-effectiveness.

Kerlikowske K, Salzmann P, Phillips KA, Cauley JA, Cummings SR.

JAMA. 1999 Dec 8;282(22):2156-63.

PMID:
10591338
5.

Costs and benefits of different strategies to screen for cervical cancer in less-developed countries.

Mandelblatt JS, Lawrence WF, Gaffikin L, Limpahayom KK, Lumbiganon P, Warakamin S, King J, Yi B, Ringers P, Blumenthal PD.

J Natl Cancer Inst. 2002 Oct 2;94(19):1469-83.

PMID:
12359856
6.

The cost-effectiveness of screening mammography beyond age 65 years: a systematic review for the U.S. Preventive Services Task Force.

Mandelblatt J, Saha S, Teutsch S, Hoerger T, Siu AL, Atkins D, Klein J, Helfand M; Cost Work Group of the U.S. Preventive Services Task Force.

Ann Intern Med. 2003 Nov 18;139(10):835-42. Review.

PMID:
14623621
8.

Mammography screening for older women with and without cognitive impairment.

Messecar DC.

J Gerontol Nurs. 2000 Apr;26(4):14-24; quiz 52-3.

PMID:
11272962
9.

Cost effectiveness of mammography screening for Chinese women.

Wong IO, Kuntz KM, Cowling BJ, Lam CL, Leung GM.

Cancer. 2007 Aug 15;110(4):885-95. Erratum in: Cancer. 2010 Jan 15;116(2):540.

10.

Cost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging.

Plevritis SK, Kurian AW, Sigal BM, Daniel BL, Ikeda DM, Stockdale FE, Garber AM.

JAMA. 2006 May 24;295(20):2374-84.

PMID:
16720823
11.

Personalizing mammography by breast density and other risk factors for breast cancer: analysis of health benefits and cost-effectiveness.

Schousboe JT, Kerlikowske K, Loh A, Cummings SR.

Ann Intern Med. 2011 Jul 5;155(1):10-20. doi: 10.7326/0003-4819-155-1-201107050-00003.

12.

Cost-effectiveness of breast cancer screening in women on dialysis.

Wong G, Howard K, Chapman JR, Craig JC.

Am J Kidney Dis. 2008 Nov;52(5):916-29. doi: 10.1053/j.ajkd.2008.06.015. Epub 2008 Sep 11.

PMID:
18789566
13.

Benefits, harms, and costs for breast cancer screening after US implementation of digital mammography.

Stout NK, Lee SJ, Schechter CB, Kerlikowske K, Alagoz O, Berry D, Buist DS, Cevik M, Chisholm G, de Koning HJ, Huang H, Hubbard RA, Miglioretti DL, Munsell MF, Trentham-Dietz A, van Ravesteyn NT, Tosteson AN, Mandelblatt JS.

J Natl Cancer Inst. 2014 May 28;106(6):dju092. doi: 10.1093/jnci/dju092. Print 2014 Jun.

14.

Benefits, harms, and cost-effectiveness of supplemental ultrasonography screening for women with dense breasts.

Sprague BL, Stout NK, Schechter C, van Ravesteyn NT, Cevik M, Alagoz O, Lee CI, van den Broek JJ, Miglioretti DL, Mandelblatt JS, de Koning HJ, Kerlikowske K, Lehman CD, Tosteson AN.

Ann Intern Med. 2015 Feb 3;162(3):157-66. doi: 10.7326/M14-0692.

15.

Cost-effectiveness analysis of mammography and clinical breast examination strategies: a comparison with current guidelines.

Ahern CH, Shen Y.

Cancer Epidemiol Biomarkers Prev. 2009 Mar;18(3):718-25. doi: 10.1158/1055-9965.EPI-08-0918. Epub 2009 Mar 3.

16.

The cost-effectiveness of mammographic screening strategies.

Lindfors KK, Rosenquist CJ.

JAMA. 1995 Sep 20;274(11):881-4. Erratum in: JAMA 1996 Jan 10;275(2):112.

PMID:
7674501
17.

Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India.

Okonkwo QL, Draisma G, der Kinderen A, Brown ML, de Koning HJ.

J Natl Cancer Inst. 2008 Sep 17;100(18):1290-300. doi: 10.1093/jnci/djn292. Epub 2008 Sep 9.

PMID:
18780864
18.

Cost-effectiveness of breast MR imaging and screen-film mammography for screening BRCA1 gene mutation carriers.

Lee JM, McMahon PM, Kong CY, Kopans DB, Ryan PD, Ozanne EM, Halpern EF, Gazelle GS.

Radiology. 2010 Mar;254(3):793-800. doi: 10.1148/radiol.09091086.

19.

Cost-effectiveness of MRI compared to mammography for breast cancer screening in a high risk population.

Moore SG, Shenoy PJ, Fanucchi L, Tumeh JW, Flowers CR.

BMC Health Serv Res. 2009 Jan 13;9:9. doi: 10.1186/1472-6963-9-9.

20.

Cost effectiveness of the NHS breast screening programme: life table model.

Pharoah PD, Sewell B, Fitzsimmons D, Bennett HS, Pashayan N.

BMJ. 2013 May 9;346:f2618. doi: 10.1136/bmj.f2618. Erratum in: BMJ. 2013;346:f3822.

Supplemental Content

Support Center